Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatocytic globules in end-stage hepatic disease: relationship to alpha1-antitrypsin phenotype.

American journal of clinical pathology - 1 Jun 1997

Iezzoni J C, Gaffey M J, Stacy E K, Normansell D E

Abstract excerpt

Hepatic explant specimens from 171 patients with cirrhosis were examined to determine the incidence of periodic acid-Schiff (PAS)-positive diastase-resistant globules (PDRGs) in end-stage hepatic disease and whether the globules bear a specific relationship to the alpha1-antitrypsin (A1AT) phenotype or to causes of hepatic disease other than A1AT deficiency. PAS-positive diastase-resistant globules were detected...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to alpha 1-Antitrypsin
Share to Child

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytoplasm

Share to Immunohistochemistry

Share to Isoelectric Focusing

Share to Phenotype

Source

Identifiers

PMID: 9169667
DOI: 10.1093/ajcp/107.6.692

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatocytic globules in end-stage hepatic disease: relationship to alpha1-antitrypsin phenotype.PMID 9169667Read ↗

Alpha-1 antitrypsin deficiency in patients with chronic hepatitis.Semantic proximity Read ↗

Variable degree of liver involvement in siblings with PiZZ alpha-1-antitrypsin deficiency-related liver disease.Semantic proximity Read ↗

Hepatic Parenchymal Injury in Crigler-Najjar Type I.Semantic proximity Read ↗

Pi*Z heterozygous alpha-1 antitrypsin states accelerate parenchymal but not biliary cirrhosis.Semantic proximity Read ↗

Liver disease associated with alpha 1-antitrypsin deficiency.Semantic proximity Read ↗

Frequency and significance of phenotypes for alpha1-antitrypsin deficiency in type 1 autoimmune hepatitis.Semantic proximity Read ↗

Liver cirrhosis associated with heterozygous alpha-1-antitrypsin deficiency type Pi MS and autoimmune features.Semantic proximity Read ↗

Phenotypes and Pathology of Drug-Induced Liver Disease.Semantic proximity Read ↗

Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?Semantic proximity Read ↗

HFE mutations in alpha-1-antitrypsin deficiency: an examination of cirrhotic explants.Semantic proximity Read ↗

Alpha-1-antitrypsin in the renal tubular epithelium in patients with or without alpha-1-antitrypsin deficiency.Semantic proximity Read ↗

Alpha1-antitrypsin deficiency-associated liver disease progresses slowly in some children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.